NCT05505006 2022-08-19
Management of Preoperative Anaemia in Surgical Oncology
Azienda Ospedaliera Universitaria Integrata Verona
Phase 4 Unknown
Clinical Trials
13 trialsNCT01100879 2022-05-09
AOC-MM
Vifor Pharma
Phase 4 Terminated
NCT04246021 2022-01-04
Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
King Hussein Cancer Center
Phase NA Completed
NCT02469480 2020-10-19
Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT02628860 2020-04-28
FCM
National Cancer Center, Korea
Phase 2 Completed
NCT02949947 2020-04-06
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04168346 2019-11-19
IRONSTOMACH
Helsinki University Central Hospital
Phase 4 Not yet recruiting
NCT02243735 2018-08-28
FIT
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 4 Unknown
NCT03625661 2018-08-10
CAMARA
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT01725789 2016-12-16
Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
National Cancer Center, Korea
Phase 3 Completed
NCT01701310 2016-10-28
IVICA
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT02057471 2014-02-07
Intravenous Iron: Measuring Response in Anemic Surgical Patients
Nottingham University Hospitals NHS Trust
Phase 4 Completed
NCT01101399 2013-12-18
FID-CHEMO
Vifor Pharma
Phase 3 Completed